Romo1 (58-78)[T2,9K;Q5K;S6K;M18del]

General Information


DRACP ID  DRACP04459

Peptide Name   Romo1 (58-78)[T2,9K;Q5K;S6K;M18del]

Sequence  KKMMKKGGKFGTFMAIGGIR

Sequence Length  20

UniProt ID  P60603 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C98H168N28O22S3

Absent amino acids  CDEHLNPQSVWY

Common amino acids  GK

Mass  252585

Pl  12.05

Basic residues  6

Acidic residues  0

Hydrophobic residues  5

Net charge  6

Boman Index  -1588

Hydrophobicity  -23

Aliphatic Index  44

Half Life 
  Mammalian: 1.3 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  6

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 34361008

Title  A Novel Peptide Derived from the Transmembrane Domain of Romo1 Is a Promising Candidate for Sepsis Treatment and Multidrug-Resistant Bacteria

Doi Not available

Year  2021

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  19981

DRACP is developed by Dr.Zheng's team.